Mark Abramovitz

8.9k total citations
73 papers, 5.5k citations indexed

About

Mark Abramovitz is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Mark Abramovitz has authored 73 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 14 papers in Pharmacology and 12 papers in Genetics. Recurrent topics in Mark Abramovitz's work include Receptor Mechanisms and Signaling (17 papers), Inflammatory mediators and NSAID effects (14 papers) and Genomics, phytochemicals, and oxidative stress (10 papers). Mark Abramovitz is often cited by papers focused on Receptor Mechanisms and Signaling (17 papers), Inflammatory mediators and NSAID effects (14 papers) and Genomics, phytochemicals, and oxidative stress (10 papers). Mark Abramovitz collaborates with scholars based in Canada, United States and Germany. Mark Abramovitz's co-authors include Kathleen M. Metters, Irving Listowsky, Yves Boie, Deborah Slipetz, Nicole Sawyer, Brian Leyland‐Jones, Ryszard Grygorczyk, Thomas H. Rushmore, Hisato Homma and Seishi Ishigaki and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mark Abramovitz

72 papers receiving 5.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Abramovitz 2.7k 1.6k 866 779 696 73 5.5k
R.J. Flower 2.7k 1.0× 2.8k 1.7× 1.4k 1.6× 920 1.2× 513 0.7× 106 7.9k
Joseph A. Mancini 2.2k 0.8× 3.5k 2.2× 1.0k 1.2× 1.6k 2.0× 476 0.7× 88 6.6k
Shuntaro Hara 2.7k 1.0× 1.6k 1.0× 680 0.8× 1.2k 1.5× 609 0.9× 121 5.9k
Friedrich Marks 4.7k 1.7× 1.5k 0.9× 490 0.6× 1.2k 1.5× 828 1.2× 222 8.1k
Dolores Pérez‐Sala 3.8k 1.4× 937 0.6× 922 1.1× 294 0.4× 475 0.7× 144 6.7k
Yoshihito Nakatani 1.9k 0.7× 1.9k 1.2× 487 0.6× 996 1.3× 381 0.5× 54 4.2k
Christina C. Leslie 4.9k 1.8× 768 0.5× 1.3k 1.5× 599 0.8× 479 0.7× 100 7.8k
Daniel L. Simmons 1.9k 0.7× 4.0k 2.5× 651 0.8× 1.6k 2.1× 630 0.9× 47 7.3k
Ruth M. Kramer 3.5k 1.3× 531 0.3× 837 1.0× 630 0.8× 370 0.5× 54 5.4k
Masatoshi Nakajima 5.1k 1.9× 571 0.4× 928 1.1× 610 0.8× 567 0.8× 154 9.3k

Countries citing papers authored by Mark Abramovitz

Since Specialization
Citations

This map shows the geographic impact of Mark Abramovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Abramovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Abramovitz more than expected).

Fields of papers citing papers by Mark Abramovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Abramovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Abramovitz. The network helps show where Mark Abramovitz may publish in the future.

Co-authorship network of co-authors of Mark Abramovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Abramovitz. A scholar is included among the top collaborators of Mark Abramovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Abramovitz. Mark Abramovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yuliang, Xiaoqian Lin, Jennifer C. Aske, et al.. (2019). Dasatinib attenuates overexpression of Src signaling induced by the combination treatment of veliparib plus carboplatin in triple-negative breast cancer. Cancer Chemotherapy and Pharmacology. 84(6). 1241–1256. 8 indexed citations
2.
Dey, Nandini, Brandon Young, Mark Abramovitz, et al.. (2013). Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner. PLoS ONE. 8(10). e77425–e77425. 61 indexed citations
3.
Dey, Nandini, Benjamin G. Barwick, Carlos S. Moreno, et al.. (2013). Wnt signaling in triple negative breast cancer is associated with metastasis. BMC Cancer. 13(1). 537–537. 215 indexed citations
4.
Martínez‐Marignac, Verónica L., Amélie Rodrigue, David Davidson, et al.. (2011). The Effect of a DNA Repair Gene on Cellular Invasiveness: Xrcc3 Over-Expression in Breast Cancer Cells. PLoS ONE. 6(1). e16394–e16394. 18 indexed citations
5.
Long, Qi, Brent A. Johnson, Adeboye O. Osunkoya, et al.. (2011). Protein-Coding and MicroRNA Biomarkers of Recurrence of Prostate Cancer Following Radical Prostatectomy. American Journal Of Pathology. 179(1). 46–54. 74 indexed citations
6.
Dong, Yan, Rino Stocco, Nicole Sawyer, et al.. (2010). Differential Signaling of Cysteinyl Leukotrienes and a Novel Cysteinyl Leukotriene Receptor 2 (CysLT2) Agonist, N-Methyl-Leukotriene C4, in Calcium Reporter and β Arrestin Assays. Molecular Pharmacology. 79(2). 270–278. 21 indexed citations
7.
Latterich, Martin, Mark Abramovitz, & Brian Leyland‐Jones. (2008). Proteomics: New technologies and clinical applications. European Journal of Cancer. 44(18). 2737–2741. 92 indexed citations
8.
Yamazaki, Mami, Steven W. Louie, Nicole T. Pudvah, et al.. (2005). Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport. Xenobiotica. 35(7). 737–753. 74 indexed citations
12.
Durocher, Yves, Sylvie Perret, Marie-Hélène Gaumond, et al.. (2000). A Reporter Gene Assay for High-Throughput Screening of G-Protein-Coupled Receptors Stably or Transiently Expressed in HEK293 EBNA Cells Grown in Suspension Culture. Analytical Biochemistry. 284(2). 316–326. 91 indexed citations
13.
Ungrin, Mark, et al.. (1999). An Automated Aequorin Luminescence-Based Functional Calcium Assay for G-Protein-Coupled Receptors. Analytical Biochemistry. 272(1). 34–42. 43 indexed citations
14.
Funk, Colin, et al.. (1995). Chromosomal localization of the human prostanoid receptor gene family. Genomics. 25(3). 740–742. 24 indexed citations
16.
O’Neill, Gary P., Joseph A. Mancini, Stacia Kargman, et al.. (1994). Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.. Molecular Pharmacology. 45(2). 245–254. 149 indexed citations
17.
Adam, Mohammed, Yves Boie, Thomas H. Rushmore, et al.. (1994). Cloning and expression of three isoforms of the human EP3 prostanoid receptor. FEBS Letters. 338(2). 170–174. 99 indexed citations
18.
Ishigaki, Seishi, Mark Abramovitz, & Irving Listowsky. (1989). Glutathione-S-transferases are major cytosolic thyroid hormone binding proteins. Archives of Biochemistry and Biophysics. 273(2). 265–272. 58 indexed citations
19.
Abramovitz, Mark & Irving Listowsky. (1988). Developmental Regulation of GlutathioneS-Transferases. Xenobiotica. 18(11). 1249–1254. 27 indexed citations
20.
Listowsky, Irving, Mark Abramovitz, Hisato Homma, & Yoshiro Niitsu. (1988). Intracellular Binding and Transport of Hormones and Xenobiotics by Glutathiones-Transferases. Drug Metabolism Reviews. 19(3-4). 305–318. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026